Trial Profile
A Double-blind, Randomised, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Oral Doses of V158866 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs V 158866 (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Vernalis
- 17 Mar 2016 Results published in the Drugs in R and D
- 31 Aug 2012 Results presented at the 14th World Congress on Pain.
- 23 Aug 2012 Results were presented at the World Congress on Pain (August 2012)